FDA Approves Sotorasib / Lumakras + Panitumumab / Vectibix for KRAS G12C Mutation Extending Survival Colorectal 3 Mins Read On January 16, 2025, a significant advancement in cancer treatment was announced. The FDA approved a new therapeutic option for…
CodeBreaK300 Update HRQoL in mCRC sotorasib + panitumumab vs. T/T or regorafenib Gastrointestinal 5 Mins Read OncologyTube: [00:00:00] Okay, here we are at ASCO GI 2024. We have Dominik Paul Modest, MD medical doctor from Charite,University…
